Supported by Clinical Trials and Testing
International Journal of PainThe International Journal of Pain reviewed a study that features 63 patients who experienced neuropathic pain. Over the course of 52 weeks, they were given CBD oil similar to what is in this formula. At the end of the 52 weeks, the participants reported feeling less pain and they also claimed that they did not develop any dependency toward the formula.
Journal of Biochemistry and Cell Biology
The Journal of Biochemistry and Cell Biology featured another study that found that cannabinoid compounds are an ideal approach to treating neuropathic pain. The participants in that study experienced a significant reduction in pain levels while taking CBD.
Journal of Pharmacology
Finally, the Journal of Pharmacology featured another study that commented upon the therapeutic use of CBD and its ability to reduce painful states.